Our search of the COSMIC database (https://cancer.sanger.ac.uk/cosmic) identified eight distinct somatic mutations in cancer patients that affect the BCL2 TMD, which impacted various tumor types (including high-incidence tumors such as colon, ovary, or lung cancer) (Fig. 1, Supplementary Table S1). This evidence concerns the gene BCL2 and cancer.